Nurix Therapeutics Inc (NRIX) — Cash Flow Reinvestment Rate
Nurix Therapeutics Inc (NRIX) has a Cash Flow Reinvestment Rate of 0.64x as of November 2023, reinvesting $16.96 Million (capex $2.58 Million plus investments $-14.37 Million) from operating cash flow of $26.69 Million. Explore NRIX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nurix Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Nurix Therapeutics Inc across 1 annual periods. Also explore NRIX current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nurix Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for Nurix Therapeutics Inc. For live market cap and broader valuation context, see Nurix Therapeutics Inc (NRIX) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 16.89x | $10.15 Million | $601.00K | $1.65 Million | — |